A Double-Blind, Placebo-Controlled Trial of Paromomycin for Treatment of Cryptosporidiosis in Patients With Advanced HIV Disease and CD4 Counts Under 150 Cells/mm3

PHASE2CompletedINTERVENTIONAL
Enrollment

68

Participants

Timeline

Start Date

Not specified

Study Completion Date

September 30, 1996

Conditions
CryptosporidiosisHIV Infections
Interventions
DRUG

Paromomycin sulfate

Trial Locations (15)

10016

NY Univ. HIV/AIDS CRS, New York

10021

Cornell University A2201, New York

14215

SUNY - Buffalo, Erie County Medical Ctr., Buffalo

33136

Univ. of Miami AIDS CRS, Miami

43210

The Ohio State Univ. AIDS CRS, Columbus

44106

Case CRS, Cleveland

45267

Univ. of Cincinnati CRS, Cincinnati

46202

Indiana Univ. School of Medicine, Infectious Disease Research Clinic, Indianapolis

Methodist Hosp. of Indiana, Indianapolis

60611

Northwestern University CRS, Chicago

60612

Rush Univ. Med. Ctr. ACTG CRS, Chicago

60640

Weiss Memorial Hosp., Chicago

Unknown

USC CRS, Los Angeles

Washington U CRS, St Louis

Puerto Rico-AIDS CRS, San Juan

All Listed Sponsors
lead

National Institute of Allergy and Infectious Diseases (NIAID)

NIH